drugset / Trial / NCT06842589
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of patients with Multi-drug resistant SRNS
Timeline
- Start
- 2025-05-14
- Primary completion
- 2027-02-14
- Completion
- 2028-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-CD19 CAR-T cells | Cell therapy | 30000 cells/kg | — |
| Subject | anti-CD19 CAR-T cells | Cell therapy | 100000 cells/kg | — |
| Subject | anti-CD19 CAR-T cells | Cell therapy | 300000 cells/kg | — |